391 related articles for article (PubMed ID: 29673760)
1. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
[TBL] [Abstract][Full Text] [Related]
2. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.
Nagase H; Kudo D; Suto A; Yoshida E; Suto S; Negishi M; Kakizaki I; Hakamada K
Pancreas; 2017 Feb; 46(2):190-197. PubMed ID: 27846148
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290
[TBL] [Abstract][Full Text] [Related]
4. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3.
Kultti A; Pasonen-Seppänen S; Jauhiainen M; Rilla KJ; Kärnä R; Pyöriä E; Tammi RH; Tammi MI
Exp Cell Res; 2009 Jul; 315(11):1914-23. PubMed ID: 19285976
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.
Twarock S; Tammi MI; Savani RC; Fischer JW
J Biol Chem; 2010 Jul; 285(30):23276-84. PubMed ID: 20463012
[TBL] [Abstract][Full Text] [Related]
6. MDA-MB-231 breast cancer cell viability, motility and matrix adhesion are regulated by a complex interplay of heparan sulfate, chondroitin-/dermatan sulfate and hyaluronan biosynthesis.
Viola M; Brüggemann K; Karousou E; Caon I; Caravà E; Vigetti D; Greve B; Stock C; De Luca G; Passi A; Götte M
Glycoconj J; 2017 Jun; 34(3):411-420. PubMed ID: 27744520
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.
Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y
Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis.
Yang YM; Noureddin M; Liu C; Ohashi K; Kim SY; Ramnath D; Powell EE; Sweet MJ; Roh YS; Hsin IF; Deng N; Liu Z; Liang J; Mena E; Shouhed D; Schwabe RF; Jiang D; Lu SC; Noble PW; Seki E
Sci Transl Med; 2019 Jun; 11(496):. PubMed ID: 31189722
[TBL] [Abstract][Full Text] [Related]
9. 4-methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells.
Saito T; Tamura D; Nakamura T; Makita Y; Ariyama H; Komiyama K; Yoshihara T; Asano R
Oncol Rep; 2013 Jan; 29(1):335-42. PubMed ID: 23124556
[TBL] [Abstract][Full Text] [Related]
10. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronate synthase-2 overexpression alters estrogen dependence and induces histone deacetylase inhibitor-like effects on ER-driven genes in MCF7 breast tumor cells.
Vanneste M; Hanoux V; Bouakka M; Bonnamy PJ
Mol Cell Endocrinol; 2017 Mar; 444():48-58. PubMed ID: 28137613
[TBL] [Abstract][Full Text] [Related]
12. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.
Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S
J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of hyaluronan inhibition in desmoid tumors.
Briggs A; Rosenberg L; Buie JD; Rizvi H; Bertagnolli MM; Cho NL
Carcinogenesis; 2015 Feb; 36(2):272-9. PubMed ID: 25556151
[TBL] [Abstract][Full Text] [Related]
14. HAS2 and CD44 in breast tumorigenesis.
Heldin P; Basu K; Kozlova I; Porsch H
Adv Cancer Res; 2014; 123():211-29. PubMed ID: 25081531
[TBL] [Abstract][Full Text] [Related]
15. A novel role of low molecular weight hyaluronan in breast cancer metastasis.
Wu M; Cao M; He Y; Liu Y; Yang C; Du Y; Wang W; Gao F
FASEB J; 2015 Apr; 29(4):1290-8. PubMed ID: 25550464
[TBL] [Abstract][Full Text] [Related]
16. Role of Hyaluronan and Glucose on 4-Methylumbelliferone-inhibited Cell Proliferation in Breast Carcinoma Cells.
Wang R; Zhou W; Wang J; Liu Y; Chen Y; Jiang S; Luo X; Stupack DG; Luo N
Anticancer Res; 2015 Sep; 35(9):4799-805. PubMed ID: 26254370
[TBL] [Abstract][Full Text] [Related]
17. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells.
Li Y; Li L; Brown TJ; Heldin P
Int J Cancer; 2007 Jun; 120(12):2557-67. PubMed ID: 17315194
[TBL] [Abstract][Full Text] [Related]
18. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer.
Koltai T; Reshkin SJ; Carvalho TMA; Cardone RA
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921242
[TBL] [Abstract][Full Text] [Related]
20. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
